Mesangioblasts transplantation - a new approach to cellular therapy of myodegenerative disease

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

全文:

受限制的访问

作者简介

A. Grigoryan

编辑信件的主要联系方式.
Email: redaktor@celltranspl.ru
俄罗斯联邦

参考

  1. Emery A.E. The muscular dystrophies. Lancet 2002; 359: 687-95.
  2. Dell’Agnola C., Wang Z., Storb R. et al. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 2004; 104(13): 4311-8.
  3. Qu-Petersen Z., Deasy B., Jankowski R. et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 2002; 157: 851-64.
  4. Minasi M.G., Riminucci M., De Angelis L. et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Dev. 2002; 1 29: 2773-83.
  5. Galvez B.G., Sampaolesi M., Brunelli S. et al. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 2006; 174: 231-43.
  6. Bachrach E., Li S., Perez A.L. et al. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc. Natl. Acad. Sci. USA 2004; 101: 3581 -6.
  7. Cossu G, Sampaolesi M. New therapies for muscular dystrophy: cautious optimism. Trends Mol. Med. 2004; 10: 516-20.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2007



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 
##common.cookie##